Skip to search formSkip to main contentSkip to account menu

Modified Release Dosage Form

Known as: Modified Release, Modified Release Dose Form 
A solid, semi-solid, solution or suspension exhibiting an altered inherent rate of release of active and/or inert ingredient(s).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Development of modified release gliclazide biological macromolecules using natural biodegradable polymers.
Review
2006
Review
2006
Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation
Abstract:  Non‐compliance in solid transplantation recipients is a major factor in acute graft rejection, which influences… 
2006
2006
A Double-blind, Placebo- and Flurazepam-controlled Investigation of the Residual Psychomotor and Cognitive Effects of Modified Release Zolpidem in Young Healthy Volunteers
Abstract: Short-acting hypnotic drugs, such as zolpidem, have minimal residual effects but may not provide optimal efficacy… 
2006
2006
Enzymatic synthesis and evaluation of new novel ω-pentadecalactone polymers for the production of biodegradable microspheres
Two novel co-polymers based on ω-pentadecalactone were enzymatically synthesized by a combination of ring-opening polymerization… 
2005
2005
Cardiovascular Safety of the Oral Controlled Absorption System (OCAS) Formulation of Tamsulosin Compared to the Modified Release (MR) Formulation
Highly Cited
2004
Highly Cited
2004
Dual coated erodible microcapsules for modified release of diclofenac sodium.
Review
2004
Review
2004
Modified release tacrolimus.
Modified Release (MR) tacrolimus is an extended release formulation of tacrolimus (Prograf) administered once daily in the… 
2004
2004
Polymers-gamma ray interaction. Effects of gamma irradiation on modified release drug delivery systems for oral administration.
2003
2003
Replacement of Conventional Glucocorticoids by Oral pH-Modified Release Budesonide in Active and Inactive Crohn's Disease: Results of an Open, Prospective, Multicenter Trial
Glucocorticosteroids (GCS) are established in the treatment of active Crohn's ileitis and ileocolitis. Recently, the topical… 
1991
1991
Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form.
An attempt was made to evaluate some of the criteria for developing a modified release peroral dosage form for furosemide which… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)